By: Willow Shah-Neville
Antisense oligonucleotides are essentially short, single-stranded synthetic fragments of DNA or RNA that bind specifically to the target RNA sequence
Willow Shah-Neville is a Junior Reporter at Labiotech.eu. She covers a range of topics including medicine and healthcare, alternative medicine, and agriculture, with a particular focus on biotech innovations, the impact of the coronavirus, and developments in CRISPR technology. Willow's work has been featured in various publications, highlighting her insights into the intersection of biotechnology and healthcare systems.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Willow's articles mainly focus on the biotechnology and healthcare industry, particularly highlighting mergers, IPOs, and innovative companies. She seems to rely heavily on press releases and data in her coverage.
To effectively reach out to Willow with a pitch, consider providing detailed information backed by solid data about groundbreaking developments or innovations within the biotech sector. Additionally, if you have insights into emerging trends or significant investments within this field supported by credible sources or data, it may capture her attention.
Given the varied topics she covers related to biotech such as diabetes treatments, AI drug discovery companies and NASH treatments among others; pitching stories that align with these specific subtopics could be of interest to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .